Jun 17, 2021 · Tampa, FL – (Business Newswire – June 17, 2021) – Alzamend Neuro, Inc. (“Alzamend”), a preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, today announced the closing of its initial public offering of 2,500,000 shares of its common stock and full exercise of the underwriter’s ... Alzamend’s initial public offering sold 2.5M shares of stock at the $5 price that company had expected from the get-go. The company also granted underwriters the option to buy 375,000 additional ...3 days ago · The reported $0.44 earnings per share for the quarter. Alzamend Neuro has generated ($1.51) earnings per share over the last year ( ($1.51) diluted earnings per …Alzamend Neuro, Inc. (ALZN) Stock Price, Quote & News - Stock Analysis 0.860 -0.050 (-5.49%) At close: Feb 16, 2024, 3:47 PM 0.910 +0.050 (5.81%) After-hours: Feb 16, 2024, …Feb 5, 2024 · Alzamend Neuro (ALZN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Summary of all time highs, changes and price drops for Alzamend Neuro; Historical stock prices; Current Share Price: US$0.90: 52 Week High: US$11.91: 52 Week Low Alzamend Neuro, Inc. (ALZN.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | Nasdaq: ALZN | Nasdaq The Alzamend Neuro PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.88. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.3 days ago · View Alzamend Neuro, Inc ALZN investment & stock information. Get the latest Alzamend Neuro, Inc ALZN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Dec 11, 2023 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Summary of all time highs, changes and price drops for Alzamend Neuro; Historical stock prices; Current Share Price: US$0.90: 52 Week High: US$11.91: 52 Week Low Alzamend Neuro, Inc. Common Stock (ALZN) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Nov 16, 2023 · In order to regain compliance with the Minimum Bid Price Requirement, Alzamend’s common stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days. The Minimum Bid Price Requirement was met on November 13, 2023. Not only that, but underwriters exercised their over-allotment option to purchase 375,000 additional common shares of stock at a price of $5 per share. In total, it had raised approximately $14.4 ...Based on 1 Wall Street analysts offering 12 month price targets for Alzamend Neuro in the last 3 months. The average price target is €23.07 with a high forecast of €23.07 and a low forecast of €23.07. The average price target represents a …Stock analysis for Alzamend Neuro Inc (9ZT1:Stuttgart) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Alzamend Neuro Reports Third Fiscal Quarter Financial Results and Provides a Business Update Business Wire - Thu Mar 16, 7:00AM CDT . Alzamend Neuro, Inc. (Nasdaq: …Company Contact Alzamend Neuro, Inc. 3480 Peachtree Road NE Second Floor, Suite 103 Atlanta, GA 30326 T: 844-722-6333 Feb 2, 2024 · Equities. Alzamend Neuro, Inc. (ALZN.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | Nasdaq: …... Stock quotes by finanzen.net · Home · Searchresults. "六合平台出租源码.aoz,六合 ... Alzamend Neuro Inc Registered Shs, ALZN. AIZAWA SECURITIES CO LTD, AZWSF.Nov 21, 2023 · Alzamend Neuro Inc (ALZN) $1.01 0.02 (1.52%) 15:25 EST ALZN Stock Quote Delayed 30 Minutes. 3 days ago · Overview Stock Screener Earnings Calendar Sectors Nasdaq | ALZN U.S.: Nasdaq Alzamend Neuro Inc. Watch list NEW Set a price target alert After Hours Last Updated: Feb 13, 2024 7:46 p.m. EST... Stock analysis for Alzamend Neuro Inc (ALZN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nov 21, 2023 · Alzamend Neuro Inc (ALZN) $1.01 0.02 (1.52%) 15:25 EST ALZN Stock Quote Delayed 30 Minutes. Should the Company exercise all warrants and options to invest, it would own approximately 22.6 million shares with an average cost of $2.27 per share of common stock, representing 22% of Alzamend ...Dec 11, 2023 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD ...Find the latest Alzamend Neuro, Inc. (ALZN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... NasdaqCM - NasdaqCM Real Time Price ...25 Feb 2019 ... ... Stock Issuance Alzamend ™ February 2019 25 Alzamend Neuro, Inc. ... Price per patient/yearly 10% Market Capture 20% Market Capture 30% Market ...Oct 31, 2022 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today …24 Jul 2022 ... Alzamend Neuro (ALZN) ... Alzamend Neuro (NASDAQ:ALZN) is, as you may have guessed, engaged in the battle to cure Alzheimer's disease. The stock ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Discover real-time Alzamend Neuro, Inc. Common Stock (ALZN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay …Firm. Analyst. Ascendiant Capital Markets. Edward M Woo. Maxim Group LLC. Michael Okunewitch. Alzamend Neuro, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alzamend Neuro, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or ... Alzamend Neuro (ALZN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’ s disease, bipolar disorder, major depressive disorder and ...On October 30, 2023, Alzamend Neuro (ALZN) experienced a significant decrease in their stock value, with shares trading 31.2% lower at $0.12. This decline Best stocks to buy nowATLANTA, December 11, 2023--Alzamend Neuro Receives FDA "Study May Proceed" Notice for Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug to Treat PTSDFind the latest analyst research for Alzamend Neuro, Inc. Common Stock (ALZN) at Nasdaq.com.Alzamend Neuro (ALZN) Price Target Increased by 1306.25% to 57.38 msn.com - November 2 at 12:25 AM Why Alzamend Neuro (ALZN) Stock Is Nosediving Today benzinga.com - October 30 at 3:48 PM Alzamend Neuro Announces Reverse Stock Split finance.yahoo.com - October 30 at 9:47 AMJun 15, 2021 · Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...What is the target price for Alzamend Neuro (ALZN) stock? A. The latest price target for Alzamend Neuro ( NASDAQ: ALZN) was reported by Maxim Group on Wednesday, April 12, 2023. The analyst firm ... Oct 30, 2023 · Alzamend Neuro, Inc. Stock price Deutsche Boerse AG Equities 9ZT1 US02262M4078 Biotechnology & Medical Research Delayed Deutsche Boerse AG. Other stock markets. 03:10:52 2023-10-30 am EDT 5-day change ...Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’ s disease, bipolar disorder, major depressive disorder and ...Stock split history for Alzamend Neuro since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Research Alzamend Neuro's (DB:9ZT1) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener. Stocks / Germany / Pharmaceuticals & Biotech; Alzamend Neuro DB:9ZT1 Stock Report. Last Price. €2.16. …Alzamend Neuro Inc stock price live 0.8959, this page displays NASDAQ ALZN stock exchange data. View the ALZN premarket stock price ahead of the market session or assess the after hours quote. 6 Feb 2024 ... Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily. © 2004-2024 GuruFocus.com, LLC ...Is Alzamend Neuro (NASDAQ:ALZN) the best stock in the Pharmaceutical preparations industry? Compare top ALZN competitors at MarketBeat. Skip to main content. S&P 500 4,971.11 (-0.69%) ... suggesting a potential upside of 434.76%. Alzamend Neuro has a consensus price target of $22.50, suggesting a potential upside of 2,456.82%. Given …3 days ago · The reported $0.44 earnings per share for the quarter. Alzamend Neuro has generated ($1.51) earnings per share over the last year ( ($1.51) diluted earnings per …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...Alzamend Neuro, Inc. (9ZT0.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | BOERSE MUENCHEN: 9ZT0 | BOERSE ...Release Summary. Alzamend Neuro Announces Pricing of Initial Public Offering of 2,500,000 Shares of its Common Stock at a Price to the Public of $5.00 per Share... shares of common stock at a price below such warrants' exercise price. ... shares of Alzamend Common Stock. During the term of the MCKEA Consulting Agreement ...Oct 30, 2023 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder …64.04%. Get the latest Alzamend Neuro Inc (ALZN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ... Stocks Annual Returns 52 Week High/Low Advanced Search Advanced Screen 52 Wk HL Screen Financial Ratios Indexes Sectors Market Updates IPOs SEC Filings. ... Alzamend neuro inc. Biotechnology:-Biological-Products-(No-Diagnostic-Substances) ALZN. 3500 Lenox Road NE ...Nov 16, 2023 · In order to regain compliance with the Minimum Bid Price Requirement, Alzamend’s common stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive trading days. The Minimum Bid Price Requirement was met on November 13, 2023. ... Stock quotes by finanzen.net · Home · Searchresults. "六合平台出租源码.aoz,六合 ... Alzamend Neuro Inc Registered Shs, ALZN. AIZAWA SECURITIES CO LTD, AZWSF.Alzamend Neuro, Inc. Common Stock (ALZN) ... and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance of a ...ALZN Stock Quote Price and Forecast | CNN Competitors Alzamend Neuro, Inc. ALZN About ALZN Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on... 3 days ago · Alzamend Neuro, Inc. (ALZN) Stock Price, Quote & News - Stock Analysis 0.860 -0.050 (-5.49%) At close: Feb 16, 2024, 3:47 PM 0.910 +0.050 (5.81%) After-hours: Feb 16, 2024, 4:35 PM EST Financials Statistics Forecast Profile Chart 1D 1Y -5.49% ( 1D) About ALZN ATLANTA, December 11, 2023--Alzamend Neuro Receives FDA "Study May Proceed" Notice for Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug to Treat PTSD10 Jan 2024 ... ... shares an average price of $2.38. To acquire these shares, it cost around $118,770. What's Happening: Fortress Biotech recently announced ...6 Feb 2024 ... Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily. © 2004-2024 GuruFocus.com, LLC ...3 days ago · View Alzamend Neuro, Inc ALZN investment & stock information. Get the latest Alzamend Neuro, Inc ALZN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Firm. Analyst. Ascendiant Capital Markets. Edward M Woo. Maxim Group LLC. Michael Okunewitch. Alzamend Neuro, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alzamend Neuro, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or ... What is the target price for Alzamend Neuro (ALZN) stock? A. The latest price target for Alzamend Neuro ( NASDAQ: ALZN) was reported by Maxim Group on Wednesday, April 12, 2023. The analyst firm ... Alzamend Neuro Inc stock price (ALZN) NASDAQ: ALZN. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Alzamend Neuro Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients. Find the latest Alzamend Neuro, Inc. (ALZN) stock quote, history, news and other vital information to help you with your stock trading and investing. Nov 20, 2023 · NASDAQ: ALZN. Linkedin Facebook-f Twitter Youtube Instagram. About us. Corporate Overview; Management Team; Board of Directors; Board Committees; Board Diversity Matrix; ... Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug …Stocks Annual Returns 52 Week High/Low Advanced Search Advanced Screen 52 Wk HL Screen Financial Ratios Indexes Sectors Market Updates IPOs SEC Filings. ... Alzamend neuro inc. Biotechnology:-Biological-Products-(No-Diagnostic-Substances) ALZN. 3500 Lenox Road NE ...Alzamend Neuro Inc stock price (ALZN) NASDAQ: ALZN. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Alzamend Neuro Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Nov 20, 2023 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD ...21 Jun 2021 ... Olshan acted as counsel to Alzamend Neuro, Inc. in a $14.4 million initial public offering of 2,875,000 shares of its common stock and ...Not only that, but underwriters exercised their over-allotment option to purchase 375,000 additional common shares of stock at a price of $5 per share. In total, it had raised approximately $14.4 ...16 Feb 2024 ... Cash Flows for Alzamend Neuro Inc (ALZN) from Operating Activities, Investing Activities, Financing Activities.SEC Filings. Find the latest Alzamend Neuro, Inc. (ALZN) stock quote, history, news and other vital information to help you with your stock trading and investing. Oct 31, 2022 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today …Alzamend Neuro Inc stock price (ALZN) NASDAQ: ALZN. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Alzamend Neuro Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...
3 days ago · Alzamend Neuro Inc. Watch list NEW Set a price target alert After Hours Last Updated: Feb 23, 2024 5:52 p.m. EST Delayed quote $ 0.8798 -0.02 -1.80% After Hours …. Nuclear plants near me
A high-level overview of Alzamend Neuro, Inc. (ALZN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Oct 2, 2023 · Alzamend Neuro Inc (NASDAQ: ALZN) received the FDA's "Study May Proceed" letter to initiate study AL001-BD01, a Phase 2A clinical study of AL001 for bipolar disorder type 1. The company expects ...Alzamend Neuro Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Alzamend Neuro, Inc. (ALZN) has announced a one-for-fifteen reverse stock split of its common stock. The split will be effective on October 31, 2023, and aims to regain compliance with the Minimum Bid Price Requirement of $1.00 per share to maintain listing on The Nasdaq Capital Market.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Apr 3, 2023 · ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today …Find the latest Alzamend Neuro Inc. (US02262M3088.SG) stock quote, history, news and other vital information to help you with your stock trading and investing.4 days ago · See the latest Alzamend Neuro Inc Ordinary Shares stock price (ALZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The new CUSIP number for the Common Stock will be 02262M407. The reverse stock split is part of the Company’s plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.3 days ago · Alzamend Neuro - ALZN - Stock Price Today - Zacks Alzamend Neuro (ALZN) (Delayed Data from NSDQ) $0.90 USD +0.05 (5.88%) Updated Feb 20, 2024 03:59 PM …Here's Why Alzamend Neuro Stock Is Shooting Higher Today. By Cory Renauer – Jul 23, 2021 at 12:44PM Key Points. ... Current Price. $0.92. Price as of February 9, 2024, 3:57 p.m. ET.Why Alzamend Neuro Stock Popped Today. (Motley Fool) +11.63%. Jun-17-21 04:30PM. Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriters Over-allotment Option for Gross Proceeds of $14.4 Million. (Business Wire) Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on ... Feb 2, 2024 · Equities. Alzamend Neuro, Inc. (ALZN.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | Nasdaq: ….
Popular Topics
All the leaves are brown | Nov 16, 2023 · The Compliance Notice is unrelated to the previously disclosed notice received by Alzamend from Nasdaq on September 26, 2023 regarding the minimum Market Value of Listed Securities (“MVLS”) for Alzamend’s common stock being below the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market …Under the securities purchase agreement, Alzamend has agreed to sell up to 6,666,667 shares of its common stock to DPL for $10,000,000, or $1.50 per share, and issue to DPL warrants to acquire up ...30 Oct 2023 ... The reverse stock split will become effective before the market open on October 31, 2023. Cash will be paid in lieu of fractional shares....
Family plan movie | Alzamend Neuro Inc. 3480 Peachtree Road NE. Suite 103. 2nd Floor. Atlanta, Georgia 30326. Phone 1 844 722-6333. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 04/2022.Alzamend Neuro, Inc. , a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease , bipolar disorder , major depressive disorder and......
Best bao buns near me | Sep 22, 2023 · On January 30, 2023, Nasdaq notified Alzamend that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days, and as a result, did ... 6 Feb 2024 ... Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily. © 2004-2024 GuruFocus.com, LLC ...13 Dec 2021 ... Alzamend Neuro Inc has fallen 5.98% over the past month, closing at $2.29 on November 15. During this period of time, the stock fell as low as ......
Whole foods prime member | Sep 3, 2021 · Alzamend Neuro, Inc. (Nasdaq: ALZN) visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Stephan Jackman, CEO and Director, rings the Opening Bell.Find the latest Alzamend Neuro, Inc. (ALZN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... NasdaqCM - NasdaqCM Real Time Price ......
Blackstone fried rice | ... Stock quotes by finanzen.net · Home · Searchresults. "六合平台出租源码.aoz,六合 ... Alzamend Neuro Inc Registered Shs, ALZN. AIZAWA SECURITIES CO LTD, AZWSF.Alzamend Neuro has a market cap or net worth of $6.29 million as of February 16, 2024. Its market cap has decreased by -89.84% in one year. Market Cap ... Market Cap = Stock Price * Shares Outstanding. Full Definition. Related Stocks. Company Market Cap; BioRestorative Therapies: 6.59M: Venus Concept: 6.58M: Kazia Therapeutics: 6.56M: …Jan 30, 2024 · With Alzamend Neuro stock trading at $0.87 per share, the total value of Alzamend Neuro stock (market capitalization) is $6.20M. Alzamend Neuro stock was originally listed at a price of $202.50 in Jun 15, 2021. ...
Holley performance | Why Alzamend Neuro Stock Popped Today. (Motley Fool) +11.63%. Jun-17-21 04:30PM. Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriters Over-allotment Option for Gross Proceeds of $14.4 Million. (Business Wire) Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company, which focuses on ... Clinical-stage biopharmaceutical firm Alzamend Neuro receives FDA approval for Phase IIA clinical study of AL001 as a treatment for PTSD. ... Alzamend Neuro stock plummets on 1-for-15 reverse ...Oct 30, 2023 · ATLANTA, October 30, 2023--Alzamend Neuro Announces Reverse Stock Split. ... of 0.4% based on an early Friday share price of almost $480. Meta stock was up 21.5% in midday trading following better ... ...